Trial Profile
Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2024
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil (Primary) ; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms ELDERLY
- 22 Feb 2024 Status changed from active, no longer recruiting to completed.
- 06 Nov 2023 Planned End Date changed from 15 Dec 2023 to 15 Jan 2024.
- 06 Nov 2023 Planned primary completion date changed from 15 Oct 2023 to 15 Jan 2024.